Trial
NCT00459810
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Prostate Cancer
Intervention
transdermal estradiol
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-28